Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function

Inflammatory bowel disease (IBD) is a chronic immune-mediated disorder characterized by prolonged inflammation of the gastrointestinal tract. IBD can result from gut barrier dysfunction, altered gut microbiota, and abnormal intestinal immunity induced by environmental factors in genetically suscepti...

Descripción completa

Detalles Bibliográficos
Autores principales: Son, Mijeong, Park, I Seul, Kim, Soochan, Ma, Hyun Woo, Kim, Ji Hyung, Kim, Tae Il, Kim, Won Ho, Han, Jaeyong, Kim, Seung Won, Cheon, Jae Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174989/
https://www.ncbi.nlm.nih.gov/pubmed/35693794
http://dx.doi.org/10.3389/fimmu.2022.870817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174989/
https://www.ncbi.nlm.nih.gov/pubmed/35693794
http://dx.doi.org/10.3389/fimmu.2022.870817

Ejemplares similares